Sanofi SA

SAN-FR:Euronext Paris
*Data is delayed | EUR
Last | 01/15/21 CET
81.53quote price arrow up+0.56 (+0.69%)
Volume
3,084,150
52 week range
67.65 - 95.82

...

Loading . . .

KEY STATS

  • Open80.66
  • Day High82.23
  • Day Low80.29
  • Prev Close80.97
  • 52 Week High95.82
  • 52 Week High Date07/21/20
  • 52 Week Low67.65
  • 52 Week Low Date03/16/20
  • Market Cap123,735.91M
  • Shares Out1,253.6M
  • 10 Day Average Volume2.12M
  • Dividend3.15
  • Dividend Yield3.86%
  • Beta0.45
  • 1 Year % Change-11.11

RATIOS/PROFITABILITY

  • EPS (TTM)8.96
  • P/E (TTM)9.10
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date05/04/2020
  • Div Amount3.15
  • Split Date-
  • Split Factor-

Latest SAN-FR News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Its segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and...
Serge Weinberg
Chairman
Paul Hudson
Chief Executive Officer
Jean-Baptiste Chasseloup de Chatillon
Chief Financial Officer
Karen Linehan
Executive Vice President
John Reed M.D., Ph.D.
Executive Vice President
Address
54 rue la Boetie
Paris
75008
France